Willem J Remme Selected Research

Perindopril

3/2016	Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.
12/2015	Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis.
3/2015	Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPA.
7/2013	Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease.
7/2009	Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study.
6/2009	The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.
4/2009	Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA?
2/2009	Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial.
11/2007	The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial.
11/2007	Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Willem J Remme Research Topics

Disease

31	Heart Failure 12/2015 - 01/2002
15	Coronary Artery Disease (Coronary Atherosclerosis) 03/2016 - 05/2002
12	Myocardial Infarction 12/2015 - 02/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2015 - 07/2005
6	Heart Arrest (Cardiac Arrest) 12/2015 - 04/2007
6	Stroke (Strokes) 07/2013 - 02/2005
5	Coronary Disease (Coronary Heart Disease) 04/2009 - 07/2005
3	Ischemia 12/2015 - 05/2002
3	Left Ventricular Dysfunction 02/2005 - 01/2004
2	Infarction (Infarctions) 02/2011 - 07/2009
2	Systolic Heart Failure 08/2008 - 07/2003
2	Unstable Angina 09/2007 - 03/2007
1	Drug-Related Side Effects and Adverse Reactions 12/2015
1	Diabetes Mellitus 07/2013
1	ST Elevation Myocardial Infarction 02/2011
1	Non-ST Elevated Myocardial Infarction 02/2011
1	Heart Diseases (Heart Disease) 02/2011
1	Thrombosis (Thrombus) 02/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2011
1	Ventricular Remodeling 02/2011
1	Atherosclerosis 02/2011
1	Chronic Renal Insufficiency 06/2010
1	Vascular Diseases (Vascular Disease) 06/2009
1	Renal Insufficiency (Renal Failure) 11/2007
1	Diabetic Foot 08/2007
1	Diabetic Coma 08/2007
1	Gangrene 08/2007
1	Cardiomyopathies (Cardiomyopathy) 03/2007
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 04/2006
1	Sudden Death 02/2005
1	Shock 02/2005
1	Respiratory Sounds (Crackle) 01/2002

Drug/Important Bio-Agent (IBA)

16	Perindopril FDA LinkGeneric 03/2016 - 05/2002
13	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2016 - 01/2002
13	Carvedilol (Coreg)FDA LinkGeneric 11/2007 - 07/2003
10	Metoprolol (Toprol-XL)FDA LinkGeneric 11/2007 - 07/2003
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2016 - 11/2007
3	CholesterolIBA 07/2013 - 04/2006
3	DiureticsIBA 02/2005 - 01/2002
2	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2011 - 08/2007
2	Bisoprolol (Concor)FDA LinkGeneric 02/2011 - 06/2010
2	pro-brain natriuretic peptide (1-76)IBA 02/2011 - 08/2008
1	Clopidogrel (Plavix)FDA Link 02/2011
1	Eplerenone (Inspra)FDA LinkGeneric 02/2011
1	CalciumIBA 02/2011
1	Erythropoietin FDA Link 02/2011
1	Indapamide FDA LinkGeneric 06/2009
1	Natriuretic PeptidesIBA 08/2008
1	Glucose (Dextrose)FDA LinkGeneric 08/2007
1	N 1518IBA 02/2005
1	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2004
1	Enalapril FDA LinkGeneric 01/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2002
1	Digoxin (Digitek)FDA LinkGeneric 01/2002
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2002

Therapy/Procedure

12	Therapeutics 03/2016 - 01/2002
4	Secondary Prevention 04/2009 - 04/2007
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2013
1	Percutaneous Coronary Intervention 07/2013
1	Cutaneous Administration 02/2011
1	Drug-Eluting Stents 02/2011
1	Resuscitation 09/2007